Michael Brouse Fallon MD FACP, FAASLD, AGAF
Hepatology & Liver Transplantation
Chair, Department of Medicine University of Arizona College of Medicine Phoenix
Join to view full profile
1441 N. 12th streetOffice 1082Phoenix, AZ 85006
Phone+1 602-839-5916
Dr. Fallon is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Transplant Hepatology, 1989 - 1990- Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987
University of Virginia School of MedicineClass of 1984
Certifications & Licensure
AZ State Medical License 2016 - 2028
AL State Medical License 1994 - 2025
TX State Medical License 2008 - 2024
CT State Medical License 1986 - 1995
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PathNet, Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification PowerChart (CQM), Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification FirstNet (Clinical), Cerner Corporation, 2015-2016
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsNeighbourhood Deprivation Is Associated With Greater Mortality in Patients With Alcohol-Associated Liver Disease.Leith Ghani, Claire S Faulkner, Majd B Aboona, Pradhan Hariharan, Pooja Rangan
Alimentary Pharmacology & Therapeutics. 2026-11-01 - Racial Disparities in Clinical and Cardiometabolic Outcomes Among Patients with Alcohol-Associated Liver Disease.Pradhan Hariharan, Majd B Aboona, Janet Foote, Leith Ghani, Amal Altaf
Digestive Diseases and Sciences. 2026-09-01 - 2 citationsUnmet needs in diagnosis and management of portopulmonary hypertension: How far have we reached?Michael J Krowka, Hilary M DuBrock, Sarah Raevens, Michael B Fallon
Hepatology. 2026-08-01
Press Mentions
Breaking the Cycle of Liver DamageSeptember 9th, 2025- Buffmire Lecture Sheds Light on Intimate Partner ViolenceOctober 17th, 2024
- ABRC Grant to Support Research of Lung Disease Linked to SmokingMarch 29th, 2023
Grant Support
- Novel Paxillin-FAK Inhibitors for the Treatment of Liver FibrosisFAKNOSTICS, LLC2024–2028
- Novel alveolar mechanisms of hypoxemia in hepatopulmonary syndromeUNIVERSITY OF ARIZONA2023–2027
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2008–2011
- Mediators Of Pulmonary Vasodilatation In Liver DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2008
- Pentoxifylline For Cirrhotic Patients With Hepatopulmonary SyndromeNational Center For Research Resources2005–2007
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: